SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028639
Filing Date
2018-11-08
Accepted
2018-11-08 17:11:28
Documents
48
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20180930.htm 10-Q 1618885
2 EX-10.2 toca-ex102_140.htm EX-10.2 684354
3 EX-31.1 toca-ex311_18.htm EX-31.1 8899
4 EX-31.2 toca-ex312_17.htm EX-31.2 8620
5 EX-32.1 toca-ex321_19.htm EX-32.1 6503
  Complete submission text file 0001564590-18-028639.txt   6127415

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT toca-20180930.xml EX-101.INS 1224350
7 XBRL TAXONOMY EXTENSION SCHEMA toca-20180930.xsd EX-101.SCH 35889
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20180930_cal.xml EX-101.CAL 44617
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20180930_def.xml EX-101.DEF 118282
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20180930_lab.xml EX-101.LAB 276932
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20180930_pre.xml EX-101.PRE 212786
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 181170566
SIC: 2834 Pharmaceutical Preparations